Eur J Endocrinol. 2012 Nov;167(5):727-8; author reply 729. doi: 10.1530/EJE-12-0698. Epub 2012 Aug 28.
We describe a protocol for etomidate infusion for the emergency management of hypercortisolemia. Etomidate is commenced at 2.5 mg/h and titrated subsequently according to cortisol levels. It is well tolerated without any sedative effects and can be administered safely via peripheral access for use in the general ward setting.
我们描述了一种依托咪酯输注方案,用于紧急治疗皮质醇增多症。依托咪酯起始剂量为 2.5mg/h,并根据皮质醇水平进行滴定。它具有良好的耐受性,没有镇静作用,并且可以通过外周途径安全给药,适用于普通病房环境。